Tag: pleural diseases market growth

Uncover key drivers, emerging technologies, and competitive movements shaping the pleural diseases market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Pleural Diseases Market in 2030?

The pleural diseases market size has experienced robust growth in recent years. It is projected to expand from $5.21 billion in 2025 to $5.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be linked to several factors, including the increasing incidence of respiratory diseases, a rising prevalence of pleural effusion and mesothelioma, enhanced availability of diagnostic imaging, the expansion of pulmonology services, and an increase in hospital-based respiratory care.

The pleural diseases market size is projected to experience significant expansion in the coming years. It is forecasted to reach $7.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is attributed to factors such as increasing investments in early cancer detection, a rising demand for minimally invasive diagnostics, the expansion of precision medicine approaches, a growing focus on outpatient respiratory care, and advancements in pleural disease therapeutics. Key trends during this period include the increasing adoption of advanced imaging diagnostics, the rising use of minimally invasive pleural interventions, the growing integration of molecular diagnostic tools, the expansion of early disease detection programs, and an enhanced focus on personalized treatment approaches.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Drivers Are Influencing Production Trends In The Pleural Diseases Market?

A rise in the occurrence of infectious diseases is anticipated to propel the expansion of the pleural diseases market in the future. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites. Alterations in environmental factors impacting human behavior and improvements in worldwide travel contribute to the growing incidence of infectious diseases. Conditions like bacterial pneumonia, tuberculosis, or viral infections, being infectious diseases, are capable of inducing pleural disease through the initiation of inflammation, infection, or fluid buildup within the pleural cavity. For example, in January 2023, data from the National Library of Medicine, a US-based medical library offering research and information, indicated that infectious diseases are responsible for more than 52 million deaths each year, endangering half of the global population. Moreover, roughly 14 million children under the age of five perish annually, and 70% of these fatalities stem from illnesses preventable by vaccination. Consequently, the expanding occurrence of infectious diseases fuels the growth of the pleural diseases market.

Which Segment Groups Are Influencing The Pleural Diseases Market?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Benign Pleural Tumors, Pleural Thickening Disorders, Pleural Plaques

5) By Other Disease Types: Empyema, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Which Trends Are Influencing The Development Of The Pleural Diseases Market?

Major companies operating in the pleural diseases market are concentrating on developing advanced treatment alternatives, such as convenient, ready-to-administer injectable therapies, to boost user convenience, cut down on preparation time, and reduce potential dosing errors. These ready-to-use injectable treatments are pre-formulated and pre-diluted medications that do not require reconstitution or mixing before being administered, thus ensuring accuracy, ease of use, and faster preparation. As an example, in April 2024, Amneal Pharmaceuticals, a pharmaceutical company based in the US, unveiled PEMRYDI RTU, which is the first ready-to-use formulation of pemetrexed for injection. This innovation assists individuals with pleural diseases by offering a convenient, immediately usable treatment that removes the necessity for reconstitution or dilution, decreases preparation time, lessens the risk of dosing errors, and improves availability of effective therapy for conditions such as malignant pleural mesothelioma.

Who Are The Top-Performing Companies In The Pleural Diseases Market In Recent Years?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Region Currently Holds The Largest Share Of The Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pleural Diseases Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2026, By The Business Research Company

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pleural diseases market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Pleural Diseases Market in 2030?

The pleural diseases market size has experienced robust growth in recent years. It is projected to expand from $5.21 billion in 2025 to $5.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be linked to several factors, including the increasing incidence of respiratory diseases, a rising prevalence of pleural effusion and mesothelioma, enhanced availability of diagnostic imaging, the expansion of pulmonology services, and an increase in hospital-based respiratory care.

The pleural diseases market size is projected to experience significant expansion in the coming years. It is forecasted to reach $7.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is attributed to factors such as increasing investments in early cancer detection, a rising demand for minimally invasive diagnostics, the expansion of precision medicine approaches, a growing focus on outpatient respiratory care, and advancements in pleural disease therapeutics. Key trends during this period include the increasing adoption of advanced imaging diagnostics, the rising use of minimally invasive pleural interventions, the growing integration of molecular diagnostic tools, the expansion of early disease detection programs, and an enhanced focus on personalized treatment approaches.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Drivers Are Influencing Production Trends In The Pleural Diseases Market?

A rise in the occurrence of infectious diseases is anticipated to propel the expansion of the pleural diseases market in the future. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites. Alterations in environmental factors impacting human behavior and improvements in worldwide travel contribute to the growing incidence of infectious diseases. Conditions like bacterial pneumonia, tuberculosis, or viral infections, being infectious diseases, are capable of inducing pleural disease through the initiation of inflammation, infection, or fluid buildup within the pleural cavity. For example, in January 2023, data from the National Library of Medicine, a US-based medical library offering research and information, indicated that infectious diseases are responsible for more than 52 million deaths each year, endangering half of the global population. Moreover, roughly 14 million children under the age of five perish annually, and 70% of these fatalities stem from illnesses preventable by vaccination. Consequently, the expanding occurrence of infectious diseases fuels the growth of the pleural diseases market.

Which Segment Groups Are Influencing The Pleural Diseases Market?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Benign Pleural Tumors, Pleural Thickening Disorders, Pleural Plaques

5) By Other Disease Types: Empyema, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Which Trends Are Influencing The Development Of The Pleural Diseases Market?

Major companies operating in the pleural diseases market are concentrating on developing advanced treatment alternatives, such as convenient, ready-to-administer injectable therapies, to boost user convenience, cut down on preparation time, and reduce potential dosing errors. These ready-to-use injectable treatments are pre-formulated and pre-diluted medications that do not require reconstitution or mixing before being administered, thus ensuring accuracy, ease of use, and faster preparation. As an example, in April 2024, Amneal Pharmaceuticals, a pharmaceutical company based in the US, unveiled PEMRYDI RTU, which is the first ready-to-use formulation of pemetrexed for injection. This innovation assists individuals with pleural diseases by offering a convenient, immediately usable treatment that removes the necessity for reconstitution or dilution, decreases preparation time, lessens the risk of dosing errors, and improves availability of effective therapy for conditions such as malignant pleural mesothelioma.

Who Are The Top-Performing Companies In The Pleural Diseases Market In Recent Years?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Region Currently Holds The Largest Share Of The Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pleural Diseases Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2026, By The Business Research Company

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Pleural Diseases Market Valuation Change Between Now And 2029?

There has been significant growth in the size of the pleural diseases market in recent past. It’s projected to rise from $4.86 billion in 2024 to $5.21 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Factors influencing this growth during the historic period include an increase in cases of pleural effusion, heightened awareness of pleural diseases, a greater emphasis on early diagnosis, expanded healthcare facilities, and an increase in clinical trials related to pleural disease.

The market for pleural diseases is predicted to witness a robust expansion in the coming years, increasing to $6.88 billion in 2029 with a 7.2% compound annual growth rate (CAGR). Several factors contribute to this growth within the forecast period including an uptick in cases of pleural diseases, aging population increase, rise in occupational hazards, increased clinical trials, and a growing number of diagnostic centers. The period is also expected to see significant trends such as improvements in diagnostic procedures, progress in diagnostic tools, wider acceptance of minimally invasive procedures, advancements in drug development, and the embrace of telemedicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Growth-Enabling Forces Are Impacting The Pleural Diseases Market?

The growth of the pleural diseases market is projected to be fuelled by the rising incidents of infectious diseases. These diseases are triggered by harmful microorganisms like bacteria, viruses, fungi, or parasites. Various factors, such as changes in human behavior and global travel advancements, contribute to the growing cases of these diseases. Infectious diseases like bacterial pneumonia, tuberculosis, or viral infections can lead to pleural disease as they incite inflammation, infection or fluid build-up in the pleural cavity. For example, as per the National Library of Medicine – a US-based medical library for research and information – in January 2023, over 52 million deaths annually were due to infectious diseases, putting half of the world’s population at risk. Additionally, nearly 14 million children under five years die every year, with 70% of these deaths linked to preventable diseases through vaccination. Consequently, the escalating frequency of infectious diseases propels the growth of the pleural diseases market.

What Are The Main Segment Classifications In The Pleural Diseases Market?

The pleural diseasesmarket covered in this report is segmented –

1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types

2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy

4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis

How Are Market Trends Influencing Competition In The Pleural Diseases Market?

Leading companies in the pleural diseases market are developing ready-to-use injectable therapies to improve convenience, cut preparation time, and reduce dosing errors. Ready-to-use injectables come pre-formulated and pre-diluted, eliminating the need for reconstitution. For instance, in April 2024, Amneal Pharmaceuticals, a US pharmaceutical firm, launched PEMRYDI RTU, the first ready-to-use form of pemetrexed for injection. This product aids patients with pleural diseases by providing easy-to-administer therapy that minimizes preparation time and dosing mistakes, improving treatment for conditions like malignant pleural mesothelioma.

Which Firms Are Driving Innovation Within The Pleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

What Are The Emerging Regional Trends Driving The Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Pleural Diseases Market Between 2025 And 2029?

The pleural diseases market has experienced robust growth in recent years. This market is projected to expand from $4.86 billion in 2024 to $5.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historic period can be attributed to the rising incidence of pleural effusion, growing awareness regarding pleural diseases, an increasing focus on early diagnosis, a growing number of healthcare facilities, and a rising number of pleural disease clinical trials.

The pleural diseases market is projected to experience substantial expansion over the upcoming years, with its valuation expected to reach $6.88 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from several factors, including an increase in the prevalence of pleural diseases, an expanding aging population, a rise in occupational hazards, an uptick in clinical trials, and a proliferation of diagnostic centers. Key developments shaping this period encompass progress in diagnostics, enhanced diagnostic tools, the implementation of minimally invasive procedures, improvements in drug development, and the increasing embrace of telemedicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Are The Drivers Pushing New Developments In The Pleural Diseases Market?

The rising occurrence of infectious diseases is anticipated to propel the expansion of the pleural diseases market in the future. These diseases are health conditions stemming from detrimental microorganisms like bacteria, viruses, fungi, or parasites. Shifts in human behavior due to environmental factors and progress in worldwide travel contribute to the growing frequency of infectious diseases. Conditions like bacterial pneumonia, tuberculosis, or viral infections, which are infectious diseases, are capable of inducing pleural disease through the stimulation of inflammation, infection, or the buildup of fluid within the pleural cavity. As an illustration, in January 2023, data from the National Library of Medicine, a US-based medical library for research and information, indicated that infectious diseases are responsible for more than 52 million deaths each year, endangering half of the global population. Moreover, around 14 million children under the age of five perish annually, and 70% of these fatalities are linked to illnesses preventable by vaccination. Consequently, the growing incidence of infectious diseases stimulates the expansion of the pleural diseases market.

What Are The Different Segment Classifications Within The Pleural Diseases Market?

The pleural diseasesmarket covered in this report is segmented –

1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types

2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy

4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis

How Are Trends Influencing The Pleural Diseases Market?

Leading companies in the pleural diseases market are concentrating on creating innovative treatment options, such as the development of ready-to-use injectable treatments, to enhance convenience, decrease preparation time, and reduce dosing errors. These ready-to-use injectable treatments are pre-formulated, pre-diluted medications that do not require reconstitution or mixing before administration, thereby ensuring accuracy, ease of use, and reduced preparation time. For example, in April 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, unveiled PEMRYDI RTU, which is the first ready-to-use version of pemetrexed for injection. This development assists patients with pleural diseases by offering a convenient, pre-prepared treatment that eliminates the need for reconstitution or dilution, shortens preparation time, minimizes the likelihood of dosing errors, and improves access to effective therapy for conditions like malignant pleural mesothelioma.

Which Global Market Leaders Are Shaping The Future Of The Pleural Diseases Sector?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Geographies Are Emerging As Strong Markets For The Pleural Diseases Industry?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pleural Diseases Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Pleural Diseases Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there has been steady growth in the market size of pleural diseases. Expected to rise from $4.86 billion in 2024 to $5.21 billion in 2025, the market is set to experience a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the historic period include an increased incidence of pleural effusion, heightened awareness about pleural diseases, a greater emphasis on early diagnosis, an expansion in the number of healthcare facilities, and an increase in clinical trials related to pleural diseases.

Expectations are high for robust expansion in the pleural diseases market in the following years, with an anticipated growth to$6.88 billion in 2029,” representing a compound annual growth rate (CAGR) of 7.2%. This predicted growth within the market during the forecasted period can be linked to a rise in occurrences of pleural diseases, an aging population, an uptick in occupational risks, an increased quantity of clinical trials, and the swelling number of diagnostic centers. The forecasted period is expected to witness trends such as advancements in diagnostic technology, progressive diagnostic tools, the inclusion of minimally invasive procedures, enhanced drug development strategies, and the emergence of telemedicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Are the Core Growth Drivers Propelling the Pleural Diseases Market Forward?

The escalating rates of infectious diseases are predicted to propel the expansion of the pleural diseases market in the future. Infectious diseases, which encompass ailments induced by detrimental microorganisms like bacteria, viruses, fungi, or parasites, are becoming more rampant. Progressions in global travel, in conjunction with environmental modifications to human behavior, amplify the widespread nature of these infectious diseases. Unlike other diseases, bacterial pneumonia, tuberculosis, and viral infections could lead to pleural disease through instigation of inflammation, infection, or excessive fluid in the pleural cavity. For example, the National Library of Medicine, a famed medical library based in the US, reported in January 2023, that infectious diseases result in more than 52 million deaths every year, thereby jeopardizing half of the world’s total population. Moreover, each year, an estimated 14 million children below the age of five succumb to these diseases, with 70% of these fatalities being preventable via vaccinations. Consequently, the escalating rates of infectious diseases is a key factor accelerating growth in the pleural diseases market.

What Segment Types Define the Pleural Diseases Market Structure?

The pleural diseasesmarket covered in this report is segmented –

1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types

2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy

4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing thePleural Diseases Industry Evolution?

Firms of significant stature in the pleural diseases market are directing their attention towards the creation of novel treatment propositions, including ready-to-use injectable treatments which amplify convenience, slice down the time taken for preparations, and mitigate inaccuracies in dosage. The ready-to-use injectable treatments are pre-diluted, pre-formulated medications that eliminate the necessity of reconstitution or mixing before they are administered, thereby enhancing accuracy, convenience, and trimming down the preparation time. A gelid example of this advancement is Amneal Pharmaceuticals, a company based in the USA, which initiated PEMRYDI RTU, the inaugural ready-to-use variant of pemetrexed for injection, in April 2024. This innovation aids those suffering from pleural diseases by offering a treatment that is ready-to-use, eliminating the need for dilution or reconstitution, bringing down the preparation time, diminishing the possibility of dosage errors, and augmenting access to proficient therapy for ailments such as malignant pleural mesothelioma.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

What Is the Definition of the Pleural Diseases Market?

Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Pleural Diseases Market?

In recent years, the market size of pleural diseases has significantly expanded. Projected growth is expected to continue from $4.86 billion in 2024 to $5.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion in the historical period is a result of an increasing prevalence of pleural effusion, heightening awareness of pleural diseases, a growing emphasis on early detection, an increase in healthcare facilities, and a rise in clinical trials for pleural diseases.

What Growth Rate Is Forecasted for the Pleural Diseases Market by 2029?

The market for pleural diseases is anticipated to witness robust expansion in the upcoming years, expecting to reach $6.94 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be credited to an increase in pleural diseases prevalence, an escalating elderly population, a surge in occupational risks, a rising number of clinical investigations, and a mounting number of diagnostic centers. Significant trends to watch during this period include progress in diagnostic methodologies, enhancement in diagnostic tools, the uptake of minimally invasive procedures, refined drug development, and the implementation of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

Which Key Companies Are Shaping the Future of the Pleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Which Factors Are Driving Demand in the Pleural Diseases Industry?

The growth of the pleural diseases market is anticipated to be fueled by the escalating occurrence of infectious diseases. These diseases are provoked by harmful microorganisms such as fungi, parasites, bacteria, or viruses. Global travel advancements and changes in human behavior and environment contribute to the rising incidence of these diseases. Bacterial pneumonia, viral infections, and tuberculosis are examples of infectious diseases that instigate pleural disease through infection, inflammation, or the build-up of fluid in the pleural cavity. As per statistics from the National Library of Medicine, a US-based research and medical information library, in January 2023, infectious diseases were responsible for over 52 million deaths annually, endangering half of the world’s population. Additionally, about 14 million children under five years old lose their lives each year, with preventative diseases via vaccination accounting for 70% of this figure. Therefore, the spike in infectious diseases occurrence is fueling the expansion of the pleural diseases market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

How Is the Pleural Diseases Market Segmented by Several Divisions?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

What are the Emerging Market Trends Driving the Growth of the Pleural Diseases Industry?

Leading businesses in the field of pleural diseases are concentrating on pioneering new treatment choices. These include the development of ready-to-use injections aimed at enhancing comfort, shortening preparation time, and lowering the risk of dosage errors. These ready-to-use injections are pre-mixed, pre-diluted medications that do not need any reconstitution or mixing prior to administration, offering accuracy, convenience, and a shorter preparation process. For example, Amneal Pharmaceuticals, a pharmaceutical firm based in the United States, launched PEMRYDI RTU in April 2024. This was the first ready-to-use offering of pemetrexed for injection. This product benefits individuals suffering from pleural diseases by delivering a user-friendly, ready-to-use treatment. It does away with the necessity for reconstitution or dilution, shortens the preparation time, reduces the chance of dosage errors, and enhances the accessibility of effective treatments for conditions such as malignant pleural mesothelioma.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Regions Are Driving Growth in the Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

This Report Delivers Insight On:

1. How big is the pleural diseases market, and how is it changing globally?

2. Who are the major companies in the pleural diseases market, and how are they performing?

3. What are the key opportunities and risks in the pleural diseases market right now?

4. Which products or customer segments are growing the most in the pleural diseases market?

5. What factors are helping or slowing down the growth of the pleural diseases market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the pleural diseases industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Pleural Diseases Market From 2025 To 2029?

There has been substantial growth in the market size of pleural diseases in the past few years. With an expected rise from $4.86 billion in 2024 to $5.23 billion in 2025, it is set to experience a compound annual growth rate (CAGR) of 7.6%. This growth during the prior period can be tied to factors such as the growing number of cases of pleural effusion, enhanced awareness of pleural diseases, an increased emphasis on early detection, amplification of healthcare facilities, and a surge in clinical trials related to pleural diseases.

Expectations are high for robust expansion in the pleural diseases market size in the coming years, with a projection to reach $6.94 billion by 2029, having a compound annual growth rate (CAGR) of 7.3%. This anticipated increase within the forecast period is linked to several factors including an upsurge in pleural diseases prevalence, an aging population trend, growing instances of occupational hazards, an escalation in clinical trials, and the proliferation of diagnostic centers. Key trends projected for this period include enhancements in diagnostic procedures and tools, the embracing of less invasive procedures, boosts in drug development, and the implementation of telemedicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pleural Diseases Market?

The rise in the occurrence of infectious diseases is projected to instigate the expansion of the pleural diseases market in the future. Such diseases, triggered by harmful microorganisms including bacteria, viruses, fungi, or parasites, are influenced by shifts in human behavior and advancements in international travel. Certain infectious diseases, like bacterial pneumonia, tuberculosis, or viral infections, could lead to pleural disease by inciting inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, the National Library of Medicine, which is a US-based medical library for research and information, reported that infectious diseases are responsible for over 52 million deaths yearly, putting half of the world’s population in danger. Moreover, around 14 million children less than five years of age die each year, with 70% of these deaths linked to preventable diseases through vaccination. Thus, the escalating occurrence of infectious diseases fuels the advancements in the pleural diseases market.

Which Key Market Segments Comprise the Pleural Diseases Market and Drive Its Revenue Growth?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Which Areas Are Leading Regions in the Pleural Diseases Market Expansion Across the Globe?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePleural Diseases Market Over the Coming Years?

Top firms in the pleural diseases market are channeling their efforts into creating innovative treatments, including ready-to-use injectable medicines, with an aim to elevate convenience, cut down on preparation time, and limit dosage mistakes. These injectable solutions come pre-mixed and pre-diluted, making them ready for use without needing any additional reconstitution or mixing. This ensures precision, simplicity and a quicker preparation period. For instance, in April 2024, Amneal Pharmaceuticals, an American pharmaceutical firm, introduced PEMRYDI RTU, the first-of-its-kind ready-to-use version of pemetrexed for injection. This offers individuals suffering from pleural diseases a handy, ready-to-use treatment that eliminates the reconstitution or dilution process, abbreviates preparation time, curtails the possibility of dosage mistakes, and enhances availability to effective treatment for diseases like malignant pleural mesothelioma.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

How Is the Pleural Diseases Market Conceptually Defined?

Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pleural Diseases Market?

The rising occurrence of infectious diseases is anticipated to propel the pleural diseases market growth in the future. Infectious diseases are conditions brought on by destructive microorganisms such as bacteria, viruses, fungi, or parasites. Variations in human behavior due to environmental changes and advancements in global travel contribute to the increasing occurrence of these diseases. Diseases like bacterial pneumonia, tuberculosis, or viral infections can result in pleural disease by instigating inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, as per the National Library of Medicine, a US-based medical research and information library, infectious diseases are responsible for more than 52 million deaths yearly, thereby jeopardizing half of the global population. Moreover, each year, around 14 million children who are below the age of five die, and about 70% of these deaths are attributable to preventable diseases through vaccination. Thus, the rising occurrence of infectious diseases is stimulating the growth of the pleural diseases market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What is the Predicted Annual Growth Rate of thePleural Diseases Market Impact Industry Trends by 2034?

The market size for pleural diseases has seen significant growth in the past few years. Expected to rise from $4.86 billion in 2024 to $5.23 billion in 2025, the market will exhibit a compound annual growth rate (CAGR) of 7.6%. This growth trajectory during the historical period can be credited to factors such as increasing incidence of pleural effusion, heightened awareness of pleural diseases, a greater emphasis on early diagnosis, an escalation in the number of healthcare facilities, and an increase in clinical trials related to pleural diseases.

Expectations are high for substantial growth in the pleural diseases market in the upcoming years, with projections predicting it will reach $6.94 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this expected growth during the forecast period include increasing instances of pleural diseases, a growing aging populace, a rise in occupational hazards, an increased number of clinical trials, and a growth in diagnostic centers. Key trends projected for the forecasting period involve progress in diagnostics and diagnostic tools, preference for minimally invasive procedures, improved drug development, and the increased adoption of telemedicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

What Are the Key Market Innovations in thePleural Diseases Market Over the Coming Years?

Leading firms in the pleural diseases market are dedicating resources to the development of new treatment alternatives, including the creation of ready-to-use injectable treatments, to enhance patient convenience, lessen preparation time, and decrease dosing mistakes. These ready-to-use injectable treatments are pre-formulated and pre-diluted medications which do not need any further mixing or reconstitution before being administered, thereby ensuring accuracy, convenience, and a shorter preparation time. For example, Amneal Pharmaceuticals, an American pharmaceutical firm, introduced PEMRYDI RTU in April 2024, becoming the first company to launch a ready-to-use version of pemetrexed for injection. This has benefited patients with pleural diseases by providing a hassle-free, ready-for-use treatment that removes the necessity for further dilution or reconstitution, cuts down preparation time, lessens the likelihood of dosage errors, and enhances access to efficient treatment for disorders like malignant pleural mesothelioma.

Who Are the Top Companies Driving Innovation and Growth in thePleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Key Market Segments Comprise the Pleural Diseases Market and Drive Its Revenue Growth?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Which Regions Are Emerging as Leaders in the Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Pleural Diseases Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: